Capricor Therapeutics, Inc.
CAPRNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $332.50M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.96$40.37
- Volume (live)
- -
- Avg. volume (3M)
- 3.27M
Capricor Therapeutics (CAPR) Stock Price & Financial Analysis
Capricor Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.69 - $5.95 |
|---|---|
| 52-Week High | $40.37 |
| 52-Week Low | $2.96 |
| Open | $5.91 |
| Volume (last close) | 1.55M |
| Average Volume (3M) | 3.27M |
| 50-Day MA | $8.04 |
|---|---|
| 200-Day MA | $21.43 |
| 1-Year Change | 0.00% |
| Market Cap | 332.50M |
|---|---|
| Shares Outstanding | 57.93M |
| Price to Book (P/B) | 1.35 |
| EV/EBITDA | 0.49 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Capricor Therapeutics at a Glance
As of the Oct 26, 2026 close, Capricor Therapeutics (CAPR) has a market capitalization of $332.50M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $20.94M in cash and securities against $91.05M of debt, a net debt position of $70.11M.
Capricor Therapeutics does not currently pay a dividend.
The share price is up 0.00% over the past year. At $5.74 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $2.96 to $40.37, below its 200-day moving average of $21.43.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $27.00, 370.4% above the Oct 26, 2026 close.
Frequently Asked Questions About Capricor Therapeutics
What is the current stock price for CAPR?
As of the Oct 26, 2026 close, CAPR stock trades at $5.74. The 52-week range is $2.96–$40.37, with a day range of $5.69–$5.95.
What is the P/E ratio for CAPR?
The P/E ratio (Price-to-Earnings) for CAPR is shown in the Key Statistics section. This valuation metric helps compare Capricor Therapeutics, Inc. to industry peers.
Does CAPR pay dividends?
Capricor Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CAPR?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for CAPR is Hold. The average 12-month price target is $27.00, a 370.4% upside from the Oct 26, 2026 close of $5.74.
What is the market cap of CAPR?
As of the Oct 26, 2026 close, Capricor Therapeutics's market capitalization is $332.5M, classifying it as a small-cap company. Capricor Therapeutics operates in the Healthcare sector within the Biotechnology industry.